Il-10 signaling reduces survival in mouse models of synucleinopathy
Abstract Parkinson’s disease (PD) and related synucleinopathies are characterized by chronic neuroinflammation leading to the premise that anti-inflammatory therapies could ameliorate synucleinopathy and associated sequelae. To test this idea, we used recombinant adeno-associated viruses (AAV) to ex...
Saved in:
Main Authors: | Samuel G. Cockey, Karen N. McFarland, Emily J. Koller, Mieu M. T. Brooks, Elsa Gonzalez De La Cruz, Pedro E. Cruz, Carolina Ceballos-Diaz, Awilda M. Rosario, Yona R. Levites, David R. Borchelt, Todd E. Golde, Benoit I. Giasson, Paramita Chakrabarty |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7d31e8435b0349f4ac0351ba14562121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice
by: Tuhina Prasad, et al.
Published: (2017) -
Author Correction: IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis
by: Michael R. Strickland, et al.
Published: (2021) -
Autophagy in α-Synucleinopathies—An Overstrained System
by: Lisa Fellner, et al.
Published: (2021) -
Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy
by: Jessica S. Fortin, et al.
Published: (2021) -
Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
by: Souvarish Sarkar, et al.
Published: (2020)